Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Imunon Inc has a consensus price target of $18.67 based on the ratings of 3 analysts. The high is $29 issued by EF Hutton on November 7, 2024. The low is $12 issued by HC Wainwright & Co. on November 11, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., EF Hutton, and EF Hutton on November 11, 2024, November 7, 2024, and October 31, 2024, respectively. With an average price target of $23.33 between HC Wainwright & Co., EF Hutton, and EF Hutton, there's an implied 2816.30% upside for Imunon Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Imunon (NASDAQ:IMNN) was reported by HC Wainwright & Co. on November 11, 2024. The analyst firm set a price target for $12.00 expecting IMNN to rise to within 12 months (a possible 1399.81% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Imunon (NASDAQ:IMNN) was provided by HC Wainwright & Co., and Imunon maintained their buy rating.
There is no last upgrade for Imunon
There is no last downgrade for Imunon.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imunon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imunon was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.
While ratings are subjective and will change, the latest Imunon (IMNN) rating was a maintained with a price target of $14.00 to $12.00. The current price Imunon (IMNN) is trading at is $0.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.